SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459958. A total of 3 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,454,000 | +17.2% | 72,500 | +0.1% | 0.01% | +66.7% |
Q2 2022 | $2,094,000 | +185.3% | 72,400 | +218.9% | 0.00% | +200.0% |
Q1 2022 | $734,000 | +4.9% | 22,700 | -5.4% | 0.00% | 0.0% |
Q4 2021 | $700,000 | +1455.6% | 24,000 | +1311.8% | 0.00% | – |
Q3 2021 | $45,000 | -30.8% | 1,700 | -19.0% | 0.00% | – |
Q2 2021 | $65,000 | -63.5% | 2,100 | -69.1% | 0.00% | – |
Q1 2021 | $178,000 | +76.2% | 6,800 | +70.0% | 0.00% | – |
Q4 2020 | $101,000 | +18.8% | 4,000 | -2.4% | 0.00% | – |
Q3 2020 | $85,000 | -89.8% | 4,100 | -88.3% | 0.00% | -100.0% |
Q2 2020 | $831,000 | -8.0% | 35,000 | -30.3% | 0.00% | -42.9% |
Q1 2020 | $903,000 | -74.3% | 50,200 | -66.1% | 0.01% | -70.8% |
Q4 2019 | $3,518,000 | -9.1% | 148,300 | +5.3% | 0.02% | -22.6% |
Q3 2019 | $3,872,000 | +882.7% | 140,900 | +1084.0% | 0.03% | +675.0% |
Q2 2019 | $394,000 | -49.8% | 11,900 | -46.9% | 0.00% | -55.6% |
Q1 2019 | $785,000 | +27.0% | 22,400 | +20.4% | 0.01% | +80.0% |
Q4 2018 | $618,000 | -31.0% | 18,600 | +4.5% | 0.01% | -28.6% |
Q3 2018 | $896,000 | -28.7% | 17,800 | -15.2% | 0.01% | -36.4% |
Q2 2018 | $1,257,000 | +134.5% | 21,000 | +79.5% | 0.01% | +120.0% |
Q1 2018 | $536,000 | +169.3% | 11,700 | +134.0% | 0.01% | +400.0% |
Q4 2017 | $199,000 | -82.8% | 5,000 | -82.7% | 0.00% | -90.0% |
Q3 2017 | $1,156,000 | -48.2% | 28,900 | -44.2% | 0.01% | -56.5% |
Q2 2017 | $2,233,000 | +76.5% | 51,800 | +28.2% | 0.02% | +53.3% |
Q1 2017 | $1,265,000 | +78.9% | 40,400 | +44.3% | 0.02% | +114.3% |
Q4 2016 | $707,000 | -27.6% | 28,000 | -29.1% | 0.01% | -36.4% |
Q3 2016 | $977,000 | -13.1% | 39,500 | -28.4% | 0.01% | -15.4% |
Q2 2016 | $1,124,000 | +87.6% | 55,200 | +40.5% | 0.01% | +62.5% |
Q1 2016 | $599,000 | -31.2% | 39,300 | -39.4% | 0.01% | -20.0% |
Q4 2015 | $871,000 | -21.2% | 64,800 | -17.8% | 0.01% | -33.3% |
Q3 2015 | $1,106,000 | -6.8% | 78,800 | +12.7% | 0.02% | -11.8% |
Q2 2015 | $1,187,000 | -17.3% | 69,900 | -41.1% | 0.02% | -26.1% |
Q1 2015 | $1,435,000 | +546.4% | 118,700 | +342.9% | 0.02% | +666.7% |
Q4 2014 | $222,000 | -19.0% | 26,800 | -14.9% | 0.00% | -25.0% |
Q3 2014 | $274,000 | -80.9% | 31,500 | -75.9% | 0.00% | -81.8% |
Q2 2014 | $1,432,000 | -53.2% | 130,800 | -61.8% | 0.02% | -56.9% |
Q1 2014 | $3,059,000 | +235.0% | 342,200 | +182.6% | 0.05% | +264.3% |
Q4 2013 | $913,000 | +125.4% | 121,100 | +119.0% | 0.01% | +75.0% |
Q3 2013 | $405,000 | +76.1% | 55,300 | +54.5% | 0.01% | +33.3% |
Q2 2013 | $230,000 | – | 35,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 11,900 | $394,000 | 0.00% |
SIMPLEX TRADING, LLC | 343 | $1,134,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |